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The PROTEOFORMER pipeline
feeds ribosome profiling-driven
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search space. The pipeline has
been greatly expanded and up-
dated since its first publication.
These novelties are presented
and validated with matching
MS/MS data, leading to the en-
dorsement of a set of new pro-
teoforms on MS/MS level and to
a collection of general consider-
ations for the ribosome profiling-
based proteogenomics
community.
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Steven Verbruggen‡‡‡, Elvis Ndah‡§, Wim Van Criekinge‡, Siegfried Gessulat¶,
Bernhard Kuster¶, Mathias Wilhelm¶, Petra Van Damme§**
and Gerben Menschaert‡§§
PROTEOFORMER is a pipeline that enables the auto-
mated processing of data derived from ribosome profiling
(RIBO-seq, i.e. the sequencing of ribosome-protected
mRNA fragments). As such, genome-wide ribosome oc-
cupancies lead to the delineation of data-specific trans-
lation product candidates and these can improve the
mass spectrometry-based identification. Since its first
publication, different upgrades, new features and exten-
sions have been added to the PROTEOFORMER pipeline.
Some of the most important upgrades include P-site off-
set calculation during mapping, comprehensive data pre-
exploration, the introduction of two alternative proteo-
form calling strategies and extended pipeline output
features. These novelties are illustrated by analyzing ribo-
some profiling data of human HCT116 and Jurkat data.
The different proteoform calling strategies are used
alongside one another and in the end combined together
with reference sequences from UniProt. Matching mass
spectrometry data are searched against this extended
search space with MaxQuant. Overall, besides annotated
proteoforms, this pipeline leads to the identification and
validation of different categories of new proteoforms, in-
cluding translation products of up- and downstream open
reading frames, 5 and 3 extended and truncated proteo-
forms, single amino acid variants, splice variants and
translation products of so-called noncoding regions. Fur-
ther, proof-of-concept is reported for the improvement of
spectrum matching by including Prosit, a deep neural
network strategy that adds extra fragmentation spectrum
intensity features to the analysis. In the light of ribosome
profiling-driven proteogenomics, it is shown that this al-
lows validating the spectrum matches of newly identified
proteoforms with elevated stringency. These updates and
novel conclusions provide new insights and lessons for
the ribosome profiling-based proteogenomic research
field. More practical information on the pipeline, raw
code, the user manual (README) and explanations on the
different modes of availability can be found at the GitHub
repository of PROTEOFORMER: https://github.com/
Biobix/proteoformer. Molecular & Cellular Proteomics
18: S126–S140, 2019. DOI: 10.1074/mcp.RA118.001218.
Proteogenomics describes the field where mass spectrom-
etry (MS) based proteomic research is combined with next
generation sequencing (NGS)1 based genomics, transcriptom-
ics and translatomics (1). It is an evolving field where new tools
are continuously proposed and where the discussions about
best practices are still ongoing in its community (http://
psidev.info/proteomics-informatics-standards-working-group-
charter). Main aims of the research are the improvement of
gene annotation and the analysis of the proteome complexity
(2).
To expand our knowledge about proteome complexity,
data from sequencing technologies can be used to construct
a custom database for subsequent MS searches. For exam-
ple, introducing RNA-seq results into the search space aided
in identifying splice variants (3) and single amino acid variants
(SAVs) at the proteomic level (4). Ribosome profiling (5, 6)
takes this approach even a step further. With this recent
technique, ribosome-protected mRNA fragments are ana-
lyzed with NGS leading to a genome-wide measurement of
the translation landscape. Typically, ribosomes are halted on
the position where they are translating the mRNA by using an
antibiotic. In Eukaryotes, the antibiotic cycloheximide (CHX)
stabilizes ribosomes on the mRNA sequence and prevents
further ribosomal translocation, allowing the study of elongat-
ing ribosome profiles. Other antibiotics like harringtonine
(HARR) or lactimidomycin (LTM), each with their characteristic
mode of action, have the unique ability to only stabilize initi-
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ating ribosomes, opening up the opportunity to visualize
translation initiation (7). After antibiotic treatment, samples will
be treated with nuclease so that only the ribosome-protected
fragments (RPFs) will remain and can be analyzed with NGS
(5, 6). After mapping the sequenced fragments to the refer-
ence genome, specific offsets allow to pinpoint the align-
ments onto the P-site (i.e. the exact base position where the
ribosome was translating the mRNA into a peptide product).
The offset in between the 5 end of the read and the P-site
depends on the length of the RPF. With a correct set of P-site
offsets, the subcodon resolution can be correctly disclosed
and important features of ribosome profiling, like triplet peri-
odicity and translation patterns, can be unveiled.
Ribosome profiling gathers data closer to the stage of the
final protein product than RNA-seq and as such, it serves as
a better protein expression proxy for expanding the MS
search space with sample-specific sequencing results. With
the help of a ribosome profiling extended search space, al-
ternative initiation events could be validated with matching
MS data (8–10). A few years ago, we devised PROTEO-
FORMER (11), a complete pipeline for processing ribosome
profiling information into a sequence database for MS-based
validation. This allowed to identify new protein forms (proteo-
forms) and helped the re-annotation of genomes.
Several other proteoform-predicting tools (12–17) were de-
vised over the last years, of which two are of interest for this
manuscript in particular. The first one is PRICE (12) which
infers open reading frames (ORFs) by modeling the experi-
mental noise and the stochastic processes involved in RIBO-
seq. From this model, the set of translated codons that
generates the observed reads with maximum likelihood is
determined. This is in turn the basis for the assembly of ORF
candidates. Another new interesting tool is SPECtre (13). It
focuses on modeling the triplet periodicity of ribosomal sig-
nals using a spectral coherence classifier. It is important to
note that these two new techniques can function without the
use of a parallel initiation profile sample, a hallmark that was
lacking in the former PROTEOFORMER pipeline (11).
Different search engines are available for matching the tan-
dem mass spectrometry (MS/MS) fragmentation spectra to
the different peptides in the sequence database. SearchGUI
(18) provides a user interface for combining different search
engines. The MaxQuant tool (19), with the Andromeda search
engine included (20), additionally includes quantitative analy-
ses over multiple samples at once.
For most MS search engines, only the number of fragment
ion matches is considered when comparing theoretical and
experimental spectra. Nevertheless, it has been proven
that adding intensities to the matching algorithm (MS/MS
intensity-based proteomics) enhances the identification rates
(21–23). Recently, Prosit allowed to raise identification rates
based on the application of deep learning on the protein-to-
spectrum matches (PSMs) (24). Prosit will start off by predict-
ing fragment intensities for the candidate PSMs. Based on
these predictions, additional PSM features can be derived.
Percolator (25, 26), on the other hand, is a MS post-processor
tool, enabling to combine features and scores of different MS
analysis tools. Based on a semi-supervised learning method
with support vector machines, it provides a statistical frame-
work to interpret the combined results. Percolator is thus able
to join the additional features of Prosit with the results of
canonical search engines.
Here we present all new features added to the PROTEO-
FORMER pipeline since its first publication. Ribosome profil-
ing mapping, data pre-exploration, proteoform calling strate-
gies and outputted features have been extensively improved
and expanded. Based on multiple high-depth samples of
matching MS/MS data of HCT116 and Jurkat human cell lines,
the ribosome profiling-based sequence database was searched
with MaxQuant. On top of the classical MS/MS search engines,
Prosit was applied in combination with Percolator to enhance
the peptide identification rate and provide extra confidence for
(novel) proteoform events and genome re-annotation.
We first give a short technical overview of the new features
in the experimental procedures before setting out the results
of the HCT116 and Jurkat case studies. Afterwards, we dis-
cuss the implications of these new features and results on the
general proteogenomics research field.
EXPERIMENTAL PROCEDURES
PROTEOFORMER Pipeline—Since its first publication (11), the
PROTEOFORMER pipeline has been largely redesigned and multiple
novel features have been added (Fig. 1).
First, the installation of the pipeline is now possible using Conda (27)
environments with all dependences included, facilitating a much easier
installation process for the user. Also, new modules are included mak-
ing the download of the reference information more streamlined.
Another important set of updates is related to quality and prelimi-
nary data visualization, which was underrepresented in earlier ver-
sions. This includes the dataset-specific calculation of exact P-site
offsets with Plastid (28), a feature that is important for correct base
allocation of the alignment and thus also for uncovering ribosome
profiling hallmarks like triplet periodicity (28, 29). Earlier versions of
PROTEOFORMER could only use a fixed set of default offsets. Also,
users now can verify the quality and general outlook of their mapped
RIBO-seq data more thoroughly as mQC (29) is directly embedded
into the PROTEOFORMER pipeline. A more prominent position for
FastQC (40) in the general analysis workflow is also foreseen.
A big shortcoming of the previous version was that the pipeline
always needed the combination of an elongating ribosome profile (an
untreated sample or treated with CHX) and an initiating ribosome
profile (a sample treated with HARR or LTM). Several studies only
contain the elongating profile and therefore, two new proteoform
1 The abbreviations used are: NGS, next generation sequencing;
CE, collision energy; CHX, cycloheximide; FDR, false discovery rate;
FPKM, fragments per kilobase million; GUI, graphical user interface;
HARR, harringtonine; LTM, lactimidomycin; MS, mass spectrometry;
MS/MS, tandem mass spectrometry; ORF, open reading frame;
PEFF, PSI extended FASTA format; PSI, Proteomics Standards Initi-
ative; PSM, protein-to-spectrum match; RPF, ribosome protected
fragment; SAV, single amino acid variant; SNP, single nucleotide
polymorphism; TIS, translation initiation site.
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calling techniques are extra implemented into the pipeline wherefore
this initiating profile is not necessary: PRICE (12) and SPECtre (13).
Meanwhile, the already present proteoform calling combination of
translation initiation site (TIS) and single nucleotide polymorphism
(SNP) determination (also denoted as “TIS and SNP calling”) and
proteoform assembly (for this manuscript simply termed as “classic
proteoform calling”) is also updated. If initiation profiling is available,
an extra advantage is that the three methods can be compared and
used to complement one another. If the initiation profile is absent,
PRICE and SPECtre can still be combined.
Great effort is put in combining the results of different analyses.
PROTEOFORMER is therefore now able to for instance merge the
translation products identified by the three different proteoform call-
ing techniques, eventually with removing sequence redundancy. Fur-
ther more, tools are included to further merge results with sequences
from UniProt (30). A code system (explained in more detail in the
supplemental methods) is added to the accessions in the produced
total FASTA file, allowing to track what source(s) (PROTEOFORMER
or UniProt) and which method(s) or TIS id(s) a sequence is originating
from.
The PROTEOFORMER pipeline now also exports results in the new
PSI extended FASTA format (PEFF) (http://www.psidev.info/peff).
This format provides tags to store SNP and proteoform variations in
a more structural way.
New features were illustrated by running the PROTEOFORMER
pipeline on human HCT116 colon cancer cells (11) and human Jurkat
T lymphocyte cells (31). The three different proteoform calling tech-
niques (classic, PRICE and SPECtre) were applied and results were
combined into one FASTA file. The latter was then merged with
reference information from UniProt to obtain one comprehensive
database in which both canonical products as new proteoform can-
didates are represented.
A more detailed explanation on the pipeline and its usage in this
study can be found in the supplementary experimental protocols. A
general manual of the PROTEOFORMER pipeline is available
on GitHub (https://github.com/Biobix/proteoformer/blob/master/
README.md). We also included an overview of all commands we
used to generate our data (examples_commands.md).
Matching Mass Spectrometry Analysis—Matching LC-MS/MS data
were generated in HCT116 and Jurkat cells using a Q Exactive HF
instrument. Obtained proteomics data were matched against the
comprehensive database from PROTEOFORMER using the Max-
Quant graphical user interface (GUI) (19). Additional scripts are added
to PROTEOFORMER to parse these MaxQuant results together with
the code system that is added to the FASTA file accessions. As such,
the share of each proteoform calling method in the final proteomics
identification results was rated. Further, this tracking system also
allowed to determine the origin of identifications. Identifications of
sequences provided by PROTEOFORMER but not yet included in
UniProt offered evidence for new proteoforms. Another new script
classifies the new proteoforms based on the nature of their variation.
This novel feature thus semi-automatically allows to determine the
nature of novel translation events, which is mostly the goal of pro-
teogenomics strategies.
Fragment intensity prediction with Prosit (24) was applied on the
PSMs. This allowed calculating additional spectral features. Percola-
tor (25, 26) was then used to combine the different scores and
features from both Prosit and MaxQuant. Q values of all features
(Prosit and MaxQuant) were compared with q values of only Max-
Quant features (Andromeda score and delta score).
Supplemental Experimental Procedures—Extensive experimental
procedures can be found in the supplemental materials.
RESULTS
Ribosome profiling analysis with PROTEOFORMER
Data Quality Assessment, Read Preprocessing, Alignment
and Translated Transcript Calling—The updated PROTEO-
FORMER pipeline (Fig. 1) was applied on matching RIBO-seq
and shotgun proteomics data originating from two cell lines,
human HCT116 (11) and Jurkat T cells (31). For both cell lines,
the CHX-treated (elongating ribosome profile) and LTM-
treated (initiating ribosome profile) samples were quality
checked with FastQC. The quality reports of the raw HCT116
CHX- and LTM-treated, and Jurkat CHX- and LTM-treated
read samples are respectively given in supplementary Files S1
and S2, and S3 and S4. Based on several plots (i.e. GC
content, adaptor content, duplication levels) preprocessing
and filtering of the reads is desirable. Therefore, the raw reads
were quality-trimmed and adaptors were clipped. Consecu-
tively, the reads were prefiltered against databases containing
rRNA, tRNA, sn(-o-)RNA sequences and the PhiX bacterio-
phage genome. Finally, preprocessed reads were aligned to
the human genome. For comparison purposes, Jurkat align-
ments were only allowed if they map to one unique position in
the genome, whereas HCT116 alignments can map to up to
16 positions. Mapping statistics of both prefiltering and
genomic alignment can be found in supplemental Table S1.
The obtained alignment SAM file was then again checked for
quality with FastQC. Results for the aligned HCT116 CHX-
and LTM-treated and the Jurkat CHX- and LTM-treated sam-
ples are respectively given in supplementary Files S5, S6, S7
and S8. General quality improves drastically and overall, con-
taminants and wet-lab related artifacts (e.g. translation inhib-
itor usage (32), ribonuclease treatment (33), composition of
the lysis buffer (34)) seem to be removed. This quality en-
hancement is caused by the application of adapter clipping,
quality trimming and filtering before mapping to the genome
as has been described previously (6). We recommend to
visually check the effects of these steps with FastQC, as
embedded into PROTEOFORMER. Further, visualizing quality
and metagenomic features is in our opinion good practice to
have a general understanding of the data content before
continuing with the rest of the analysis.
Besides, FastQC reports a slightly better quality for Jurkat
than for HCT116, but one must bear in mind that the read
coverage of Jurkat is around 2,5 times higher.
Ribosome profiling specific data exploration was done with
mQC. The results for the CHX- and the LTM-treated HCT116
samples are respectively given in supplementary Files S9 and
S10. For the CHX- and LTM-treated samples of Jurkat, plots
are respectively available in supplementary Files S11 and
S12. In these files, the results of the Plastid P-site offset
calculation are shown as well. Overall, the P-site determina-
tion of LTM is crispier than for CHX. Also, the higher coverage
in Jurkat allows a more precise offset calculation. In the
metagenic annotation plots of HCT116, a quite notable per-
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centage of the alignments lies in processed pseudogenes,
because of the non-unique mapping (this percentage reduced
drastically when mQC was applied on unique mapped
HCT116 data (results not shown)). In general, results of mQC
comply with what can be expected (29) and a good triplet
periodicity is observable for both cell lines.
Visualization on a more focused level is now possible by
loading the generated BedGraph files into a genome
browser, with the new option to generate RPF-specific
BedGraph files.
The rule-based transcript calling was used for all analyses.
During this calling, transcripts are recognized as truly trans-
lated if at least 85% of its exons have an elongated ribosome
profile coverage higher than a predetermined threshold (more
details on this can be found in (11)). In HCT116, it yielded 65
553 translated transcript isoforms. For Jurkat, 82 065 trans-
lated transcript isoforms were called.
Proteoform Calling—In this study, three methods of proteo-
form calling were compared: (a) the subsequent combination
of TIS calling, eventual SNP calling and proteoform assembly
(this combination is termed ‘classic proteoform calling’ from
hereon), (b) by using the PRICE algorithm (12), and (c) by using
the SPECtre algorithm (13). The two latter methods are novel
introductions in the pipeline and have the big advantage that
FIG. 1. Most important parts of the PROTEOFORMER pipeline workflow. The pipeline starts with raw reads from a ribosome profiling
experiment, provided in FASTQ format. The quality of these raw reads are checked with FastQC (40). Next, the reads are preprocessed, filtered
and mapped to the reference genome. By using P-site offsets (calculated with Plastid (28)), these alignments can be pinpointed at the base
level. Quality of the alignments and general data outlook will be checked with help of FastQC (40) and mQC (29). If the user is satisfied with
the output, one can continue with the pipeline. PROTEOFORMER will search for the transcript isoforms with translation evidence. Based on
these, the translated proteoforms can be deduced. The workflow used in the previous PROTEOFORMER (11) version can be applied (TIS
calling, SNP calling and proteoform assembly) or one can use PRICE (12) or SPECtre (13) to determine these proteoforms. All results of these
earlier steps are saved in an SQLite results database. For MS-based validation, the results can be exported, combined and even merged with
canonical information from UniProt. The end result is a FASTA file that can be used for database searching of MS/MS spectra with tools like
MaxQuant (19), SearchGUI-PeptideShaker (63, 64) or Prosit (24) in combination with Percolator (25). Several novel scripts were added to the
pipeline to use these search results for counting database hits and classifying new proteoforms and novel translation events in a semi-
automated fashion. Identifications can also be manually inspected on both ribosome (e.g. by browsing the PROTEOFORMER BedGraph files
in a genome browser environment) and MS level (MS software interface or converted MS identification files in proBAM/proBED format (57, 58)
in the same genome browser session as the BedGraph ribofiles).
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they do not require initiating ribosome profiles. This comes in
handy as many recent ribosome profiling studies lack this
translation initiation focused experiment (35). The SPECtre
method uses a reference annotation in a GTF file as a basis for
its analysis and is therefore not useful to find completely novel
proteoforms. However, it is useful to check which canonical
sequences show translation. A big drawback of this method
though, is its running time (149 h), which is significantly longer
than for the other two methods (2–4 h). These run times were
measured on 20 2.3GHz AMD Opteron™ processors on a
Linux server running Fedora Core 23 with 350Gb of RAM.
PRICE, the other new method, is constructed to find new
translated sequences solely based on ribosome profiling.
Therefore, a score model needs to be used. The developers
chose a default FDR of 10%. This means that it needs to allow
quite some false positives to find its candidates (more details
on the PRICE FDR calculation can be found in the online
methods of (12)). A less stringent FDR is for this pipeline less
a concern though as ribosome profiling is used here to obtain
ORF candidates. Stronger validation follows afterwards in the
pipeline using MS/MS data. A looser default FDR threshold
means though that a lot of canonical sequences are missed,
which is why the overlap with the other two techniques (and
especially with SPECtre) is relatively small (Fig. 2A and sup-
plemental Fig. S1). This observation is extendable to the MS
level (Fig. 2C and supplemental Fig. S4), as PRICE also lacks
at that level quite a big part of the sequences that the other
two techniques do capture. The major part of the MS identi-
fied sequences missed by PRICE but picked up by classic
proteoform calling and SPECtre, start from annotated TISs.
Nevertheless, in cases where no MS validation and no ribo-
some initiation profiling are at hand, the combination of
SPECtre and PRICE should result in a complete set of all
translated proteoforms based on solely the elongating RIBO-
seq profile.
The classic proteoform calling (combination of TIS calling
and proteoform assembly) has been upgraded over the years.
This method does not work with a score model but is rule-
based. Therefore, it is less stringent and thus aims at a sub-
sequent MS validation to exclude the false positives from that
phase. In Fig. 2A and supplemental Fig. S1, it is shown that
the classic proteoform calling gives the most complete
search space of the three techniques with a combination of
both canonical sequences and new variants. This strategy
also adds the most MS identifications attributable to one
distinct proteoform calling technique (Fig. 2A and supple-
mental Fig. S4).
Selenocysteines were introduced in the different proteo-
form calling algorithms. In the classic proteoform calling, re-
spectively 134 (0,057%) and 258 (0,053%) of the candidate
translation products contain one or multiple selenocysteines
in respectively HCT116 and Jurkat data. With the SPECtre
algorithm, respectively 47 (0,127%) and 43 (0,101%) of the
candidate products contain selenocysteines. The internal
PRICE algorithm does not take selenocysteines into account
and just classifies the “UGA” codon as a stop signal. Valida-
tion of selenocysteine-containing peptides in MS/MS was
however not possible. As these sequences constitute only a
very small portion of the search space and as selenoproteins
have been reported to only occur in specific conditions (spe-
cialized MS strategies were even developed for picking them
up (36)) and tissues (37), this was somehow to be expected.
For Jurkat data, SNPs were also included during the classic
proteoform calling. 7,15% of the candidate products contain
one or more SNPs as compared with the reference se-
quences. A trial version of PROTEOFORMER was imple-
mented that took indels into account as well. Subsequent MS
validation could not confirm any new protein variants by indel
addition (unpublished), so for the moment, indel-aware pro-
teoform calling is not included in the pipeline.
FASTA File Export and Database Combinations—FASTA
files were generated for the three different applied proteoform
calling methods for both HCT116 and Jurkat data. Redun-
dancy can be removed when generating these files, so both
files with and without remaining redundancy were exported
for all methods. Afterwards, the FASTA files of the three
different methods were merged into one comprehensive
FASTA data set, for either their redundant or nonredundant
forms. The overlap between methods found during this merg-
ing is shown in Fig. 2A and supplemental Fig. S1.
In general, the overlap between the different methods is
quite low, but this overlap enlarges tremendously once
MS/MS validation is applied (Fig 2C and supplemental Fig.
S4). It is thus essential to keep in mind that ribosome profiling
can lead to a candidate proteoform database, but not to a
database of surely present proteins. High overlap is therefore
not necessarily expected on ribosome profiling level, in con-
trast to the MS/MS level.
If redundancy was not removed in the initial database
exports, especially the classic proteoform calling method da-
tabase size is somewhat larger. The redundant database
(119,716 sequences) is 55,58% larger than the nonredundant
(76,945 sequences) for the classic proteoform calling in
HCT116. In contrast, the PRICE and SPECtre databases rise
only with respectively 4.33% (14 077 nonredundant se-
quences) and 13.59% (26,383 nonredundant sequences)
when keeping redundant sequences.
The classic proteoform calling of PROTEOFORMER is de-
signed to include different protein variants, also from different
TISs (i.e. N-terminal proteoforms) in the light of possible MS
validation afterwards. Therefore, it initially contains a lot of
overlapping sequences (e.g. extensions, truncations, splice
variants…). SPECtre on the other hand starts from a canonical
reference annotation, resulting in almost all identified candi-
date products starting from a canonical TIS location with
almost no new variants. When redundancy is not removed,
the sequences resulting from the classic proteoform calling
method remain in the database in both their canonical and
PROTEOFORMER 2.0
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variant form. Therefore, a higher overlap between SPECtre
and the classic method is seen. Also, detailed analysis re-
vealed that none of the PRICE-unique translation product
candidates start from a canonical TIS. All canonical TIS-
starting candidates identified by PRICE are in the overlap
regions with the other two methods (Fig. 2A and supple-
mental Fig. S1).
Another remarkable feature, seen in these plots, is the fact
that there is much less overlap between PRICE and the other
two approaches than between the classic proteoform call-
ing method and SPECtre. Varying the false discovery
rate (FDR) of PRICE (from 0.01 over 0.1 to 0.2) did not result
in an overlap increase with the other two methods (results
not shown). Specifically, the number of PRICE-unique vari-
ants is subject to a changing FDR, increasing with a less
strict FDR. Contrarily, the canonical sequences in the over-
lap sections (with classic and SPECtre) do not change
remarkably.
A)
C)
B)
D)
FIG. 2. Overview of the PROTEOFORMER analysis and MaxQuant identification results for Jurkat data. Different proteoform calling
methods were tested and combined in one FASTA file without removing redundancy during PROTEOFORMER run time. Sequence counts and
the overlap between methods is shown in panel A. This combined FASTA file was afterwards merged with UniProt (consisting of SwissProt
and TrEMBL) and the overlap is given in panel B. The search spaces of respectively A and B were afterwards searched with MaxQuant, leading
to the results displayed in respectively panels C and D. The amounts of MS/MS identifications on protein level for each proteoform calling
technique are given in C. The distribution of the MS/MS identifications between PROTEOFORMER and UniProt are given in D. The areas of
the Venn diagrams in subfigures C and D are log10 (x 1) transformed for better visual representation. The Venn diagrams for all other analyses
are given in supplemental Figs. S1, S2 and S4–S6.
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Next, the combined results of the three methods were
merged with all protein info from UniProt (consisting of Swiss-
Prot and TrEMBL). As the MS analysis program can sort out
the different redundant forms later by applying protein infer-
ence algorithms, the combined redundant FASTA files were
chosen for fusion with UniProt. Besides, the database size
does only increase by a factor of 0.43 when keeping redun-
dant sequences. As this is far from an exponential increase,
the negative impact on peptide and protein scoring is limited.
The overlap between sequences resulting from the PROTEO-
FORMER pipeline and those available in UniProt is presented
in Fig. 2B and supplemental Fig. S2. For HCT116, both a
version of UniProt with and without splice variants was ex-
amined. Splice variant inclusion enlarges the overlap between
UniProt and PROTEOFORMER. Also, overlap with PROTEO-
FORMER is larger for the SwissProt part of UniProt compared
with TrEMBL and by including splice variants, this effect is
even more pronounced. For the Jurkat data, the overlap has
not notably increased compared with HCT116, but the new
variants delivered by PROTEOFORMER have expanded be-
cause of the higher coverage in this data set. Detailed inves-
tigation (based on the underlying SQLite database) reveals
that all PRICE-unique candidates are new variants that do not
overlap with UniProt. The classic proteoform calling method
on the other hand gives a combination of both UniProt known
sequences and new variants. SPECtre-unique sequences are
mainly found overlapping with TrEMBL whereas sequences
shared between SPECtre and classic proteoform calling are
generally found overlapping with SwissProt.
Another new useful addition to the pipeline is the new PEFF
format, following the definition of this new format by the
HUPO PSI. This FASTA-derived format allows grouping of
the different SNPs and proteoform variants of a common
base sequence more logically together as one entry. An
example of the different proteoforms of human transcript
ENST00000000412 is given in supplemental Fig. S3. These
proteoforms can be exported in PEFF format as can be seen
in supplementary File S13, which is a snippet of a full PEFF file
generated with PROTEOFORMER.
MS/MS-based Validation with MaxQuant
Matching high-depth LC-MS/MS data over 4 replicates
were searched with the MaxQuant GUI. The full results of
these searches, together with peak and raw data, have been
deposited to the ProteomeXchange Consortium via the
PRIDE (38) partner repository with the dataset identifier
PXD011353. Search results at the protein and peptide level
are also available in supplementary Files S14–S19.
First, data were searched against the FASTA files of the
three combined proteoform calling techniques to see how
much each methodology adds to the general identification
rate at the MS level. For HCT116, both the combination proc-
ess with and without the redundancy removal was tested; for
Jurkat, only the redundant option was analyzed. A table of
identification rates at protein group, peptide and PSM level for
the different search spaces and samples can be found in
supplemental Table S2. In this table, the high coverage of the
MS/MS data is visible in the high amounts of protein groups
identified. The results coming out of these MaxQuant analy-
ses can be used to determine the share of each proteoform
calling strategy in the pool of MS/MS validated proteins, as
shown in Fig. 2C and supplemental Fig. S4. It can be ob-
served that preserving the FASTA-level redundancy, tends to
reduce the number of SPECtre-only validated sequences.
Like the ribosome profiling stage, keeping redundancy leads
to more overlap with the classic proteoform calling method,
as stated earlier. The higher coverage in the Jurkat ribosome
profiling data boosts the overlap between PRICE and the
other two proteoform calling methods (classic and SPECtre-
based), resulting in the largest number of validations residing
in the overall union of the three methods (supplemental Fig.
S4G). The higher coverage also leads to more classic proteo-
form called validations.
Peptides with selenocysteines on the contrary, could not be
identified with MaxQuant. There are some arguments though
that explain why selenocysteine could not be picked up in
MS/MS data. First, selenocysteines are present in very low
abundance in the ribosome profiling data: 43 ORFs with sel-
enocysteines of the 42,452 ORFs in total (0,1%). Second,
selenoproteins are known to be tissue specific and suscepti-
ble to expression changes as a result of processes like aging
(36). Last, very specific methods are developed to enrich and
pick up selenoproteins (36, 39). Under these specific enrich-
ment conditions, Guo et al. (36) could only pick up 22 known
selenoproteins and 5 new candidates in MS/MS data. So, for
the MS/MS run analyzed here, not specifically designed to
pick up selenocysteine-containing peptides, it is not surpris-
ing to not detect these.
In a second round, the previously mentioned PROTEO-
FORMER pipeline generated sequences were now merged
with UniProt sequences and this combined database was
used for MS/MS validation with MaxQuant. Identification rates
are shown in supplemental Table S2. The shares of the
PROTEOFORMER pipeline and UniProt in these MS searches
are shown in supplemental Fig. S5. Most of the validations are
shared, but most interesting validations are of course to be
found in the PROTEOFORMER part not overlapping with Uni-
Prot, as these contain MS/MS spectra validating new proteo-
forms and novel translation events. If the UniProt splice vari-
ants are included, roughly 50% of the earlier PROTEOFORMER-
only validations can be explained by the added splice variants
in the extended UniProt database. It illustrates the benefit of
including alternative splice isoforms in the search space. The
higher ribosome profiling coverage of the Jurkat data allows
to identify two times more validated proteoforms, while the
number of shared identified sequences remains roughly the
same. The distribution of the UniProt sequences was further
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split up between SwissProt and TrEMBL in Fig. 2D and sup-
plemental Fig. S6. Here, the overlap of PROTEOFORMER with
TrEMBL is much smaller than the overlap with SwissProt and
also smaller than the overlap between all three collections.
With a new PROTEOFORMERmodule, the group of MS/MS
validated sequences, found by the PROTEOFORMER pipeline
but not yet present in UniProt (i.e. newly identified proteo-
forms), was subdivided in more detail based on the nature of
their variations. In HCT116, respectively 109 and 52 of such
proteoforms are found outside respectively the canonical and
splice isoform-included UniProt information. In Jurkat, 107
new proteoforms outside the splicing included reference are
found. The classification of these newly validated proteoforms
is shown in Fig. 3, supplemental Fig. S7–S8 and in supple-
mentary File S20. Different sources of proteoform variation
could be validated: N- and C-terminal extensions and trunca-
tions, new splice variants, SAVs, down- and upstream ORFs,
out-of-frame ORFs and translation events in previously con-
sidered non-coding regions. Splice variants and non-coding
region proteoforms could be further classified in subcatego-
ries. For HCT116, MS/MS searches against both the merge
with the canonical (supplemental Fig. S7) and splicing-in-
cluded version (supplemental Fig. S8) of UniProt were per-
formed. Comparing the classifications of both experiments
points to a reduction of splice variants, C-terminal extensions
and N-terminal extensions and truncations in the splicing-
included case. The added splicing information in UniProt is
thus able to explain parts of certain proteoform categories
found compared with the canonical UniProt analysis. Next,
the classification for HCT116 (supplemental Fig. S8) and Ju-
rkat data (Fig. 3) can be compared. The different categories
present in the analysis of HCT116 data are also present for
Jurkat data, but some overall differences are noticeable. An
increase of proteoforms with only SAVs is observed for Jurkat
data because the SNP calling was additionally executed in
Jurkat and not in HCT116. Some of these called SNPs lead to
single amino acid substitutions (SAVs), which could be vali-
dated in peptides during the MS/MS analysis. Further,
whereas for HCT116 there are validated proteoforms found in
pseudogenes, for Jurkat, this subcategory is absent. In the
metagenic plots of the earlier mentioned mQC reports (sup-
plementary File S9), it was found that the non-unique mapping
FIG. 3. Classification of the MS-validated proteoforms found in PROTEOFORMER but not in the splicing-included UniProt database
for the Jurkat data. The proteoforms are classified based on the nature of their variation. For new splice variants and proteoforms originating
from previously considered non-coding regions, more detailed classifications are added. More information about the different classifications
is presented in supplemental Table S3.
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applied in HCT116 allows enrichment of reads in pseudogenic
regions. In Jurkat on the other hand, unique mapping was
performed. It is clear that the ribosomal signal in pseudogenic
regions for non-unique mapped experiments is also observ-
able in the form of validated pseudogenic peptides at the MS
level. An example of a new MS/MS validated proteoform can
be seen in Figs. 4A and 4B, whereas its PROTEOFORMER
proof on ribosome profiling level can be visualized on a ge-
nome browser as shown in Fig. 4C.
Proof-of-Concept Proteogenomic Experiment Using
Prosit and Percolator
For this experiment, the purpose was to try whether there
was an added value of extending the scores of Andromeda
with other features coming out of the Prosit tool, a neural
network approach for fragment intensity prediction. Percola-
tor was used to combine the Andromeda scores with the new
features from Prosit.
A first experiment consisted of comparing the q values of
the earlier MaxQuant identified PSMs between a Percolator
run with only the Andromeda scores and a second run with a
combination of both the scores of Andromeda and the new
features from Prosit. This was performed for the HCT116 data
with a search space of combined redundant PROTEO-
FORMER data merged with the canonical version of UniProt
(Fig. 5). The number of identified PSMs decreases with more
stringent q value filtering. By including not only the scores of
Andromeda but also the features calculated by Prosit, it is
possible to filter at lower q values. As such, the analysis where
Prosit features are included, can be executed at higher levels
of stringency while still maintaining a comparable number of
validated PSMs which is desired in a proteogenomic setup
where the search space tends to increase.
DISCUSSION
Since its first release (11), a lot of novel implementations
were added in the PROTEOFORMER pipeline (Fig. 1). To-
gether with the usage of high coverage MS/MS data, our
pipeline leads to the validation of a collection of novel pro-
teoforms. We here want to discuss the overall implications of
these novelties on the proteogenomics research field. Further,
we want to point out what can be learnt from our approach for
the future proteogenomic study of proteoforms and ribosome
profiling-assisted re-annotation in general.
PROTEOFORMER
Data Quality Assessment, Read Preprocessing, and Align-
ment—Data quality checks and preliminary data exploration
hold a very important position in the new PROTEOFORMER
pipeline. FastQC (40) offers a very good way to visualize the
effects of pre-mapping data clean-up and gives at the same
time a metagenomic overview of the data. These aspects are
indispensable for the downstream workflow.
The introduction of Plastid (28) improves the base resolu-
tion of the alignments to their correct P-site by calculating the
RPF length-specific offset based on the sample data. A sam-
ple-specific offset is in proteogenomics of course preferable
over fixed offsets, as also outlined in (29).
Moreover, the introduction of mQC (29) enables to visualize
even more ribosome profiling-specific features of the aligned
data. This adds a collection of quality control and general
outlook visualization to the PROTEOFORMER pipeline and
opens up new ways of visualizing ribosome-specific features
like triplet periodicity and codon usage. New quality tools for
ribosome profiling start to find ground (29, 35, 41–43) and
proteogenomic studies should not hesitate to use them.
Taken together, proteogenomic approaches should wear
high priority to quality checks, data exploration and sample-
specific P-offsets.
Proteoform Calling—As seen in the results section, each of
the three proteoform calling methods has its own pros and
cons. Depending on the goal of the analysis, one specific
method or the combination could be more suitable. In the
case of an MS validation afterwards, the combination of all
three implemented methods enables a good effort to opti-
mally enrich the search space. If you would have to rely on
one technique, the classic proteoform calling takes still the
lead with the eye on subsequent MS validation afterwards, on
the premise that initiation ribosome profiling data is available.
This is not totally unexpected as the classic method is devel-
oped to function with subsequent MS (11), in contrast to
PRICE (12) and SPECtre (13). Although, if no initiation profiling
is available (15, 44–46), PRICE and SPECtre can come in to
help. In the future, even other methods (14–17, 47) can be
introduced in the PROTEOFORMER pipeline.
There is a lot of discussion on the false positive rate of RPF
signals and on how this influences the reliability and signifi-
cance of ribosome profiling-predicted TISs and ORFs (48, 49),
even under stringent settings. Therefore, PROTEOFORMER
uses MS/MS as an important independent gold standard
technique to validate the new candidates, proposed by ribo-
some profiling. The discussion on the false positive rate of
ribosome profiling demonstrates the necessity of this subse-
quent MS/MS validation step.
Another point worth mentioning is the fact that information
from other transcriptome and translatome sequencing
sources could be considered in the PROTEOFORMER pipe-
line. As RNA-seq sequences can already be mapped with
PROTEOFORMER, the foundation stone is already laid for
transcriptome mapping. Other translatome sequencing tech-
niques like RNC-seq (50) and TRAP-seq (51) could also be
included in PROTEOFORMER in the future once these
techniques get as commonly used as ribosome profiling. This
would allow constructing candidate proteoform search
spaces from different translatomic technical angles. Further,
as some of these additional sequencing techniques acquire
longer read lengths than ribosome profiling (50), this would
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open up interesting opportunities for developing pipeline
modules to discover new splice variants.
FASTA File Export and Database Combinations—Different
options were developed for combining the FASTA exports of
different PROTEOFORMER analysis strategies as well as for
merging with reference sequences from UniProt. The first
release of PROTEOFORMER did not allow these merges and
users needed to consecutively search spectral data against
UniProt first and afterward against the custom PROTEO-
FORMER database (11). Now, by merging sequences from
UniProt and PROTEOFORMER into one database, the pro-
teomics matching is done for all sequences at once in one
search run with a set search space size. This eliminates
identification biases because of differing search space sizes
and thus facilitates the overall evaluation and interpretation.
We are convinced that this strategy is useful in lots of other
proteogenomic research cases. Further, the devised combi-
nation options can also be used to compare other sets of
FIG. 4. An N-terminal extension found with PROTEOFORMER and validated with MS/MS data. A, The extended proteoform has one
extra peptide mapped, compared with the canonical protein. This extra peptide overlays the canonical initiation site and validates thus the
appearance of this N-terminal extended proteoform with MS/MS. The peptide is confirmed with 4 fragmentation spectra of comparable quality.
B, One of these 4 spectra is given as an example. C, View of the N-terminal extension on ribosome profiling level in the UCSC genome browser.
The alternative near-cognate TIS (“ACG”) of the N-terminal extension is clearly marked in the LTM data. The CHX data signal is transformed
using the following y  ln(x1). The triplet periodicity clearly pops up, both in the canonical part as well as in the N-terminal extension of the
CHX-treated data. The reading frame is on the antisense strand.
FIG. 5. Comparison of the q values between a
Percolator run with only Andromeda scores and a
run with combined features from both Androm-
eda and Prosit. This analysis was executed for the
HCT116 MS data searched against a combined re-
dundant PROTEOFORMER database merged with
the canonical version of UniProt. A, Analysis for all
PSMs earlier identified with MaxQuant. B, Analysis
of the PSMs earlier identified with MaxQuant be-
cause of sequences in the search space resulting
solely from the PROTEOFORMER pipeline (i.e. novel
proteoform events).
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strategies other than the comparison between proteoform
calling methods performed in this manuscript (e.g. different
transcript calling methods, different PROTEOFORMER pa-
rameter sets…). On the downside, combined databases lead
to bigger search space sizes and this has a mild but negative
effect on the proteomics FDR. Therefore, novel MS/MS iden-
tification strategies can be applied to overcome this problem
(see infra).
As some search engines (e.g. Comet (52), ProteoMapper
(53)), phpMS (54)) start to accept also the PEFF format (http://
www.psidev.info/peff), another new option included in
PROTEOFORMER allows exporting the results in this new
format. The rich and strictly defined PEFF header information,
including details about sequence variants, promises to be a
helpful tool to communicate precise results easier between
different proteogenomic tools (55). The more tools that are
programmed to handle this format, the broader the applica-
bility of this novel format will be.
MS/MS-based Validations with MaxQuant
First, we described MS/MS-based validation experiments
with a focus on combining different proteoform calling strat-
egies. Not much difference in the number of MS/MS identifi-
cations is observed between the combination with or without
search space redundancy removal. This is mostly because the
protein inference algorithm of MaxQuant (19, 20) (or other
MS/MS identifications tools) bundles the redundant se-
quences in protein groups. It is however useful to keep the
redundancy if there is a merge with UniProt planned after-
wards, as the canonical sequences will then not be removed
by their eventual longer extension variants. Keeping this re-
dundancy does not mean that the database size explodes
exponentially as seen in RNA-seq assisted proteogenomic
studies (3, 4). Ribosome profiling still considers only informa-
tion of one reading frame in contrast to the 3- or 6-frame
analysis necessary for RNA-seq (11). As such, the effect on
MS/MS search FDR is limited. Further, in supplemental Table
S2 it is clear that the number of identifications do not differ
significantly between searches against a redundant and a
nonredundant search space (4 330 identified protein groups
for redundant versus 4 322 for nonredundant). So, in contrast
to RNA-seq supported proteogenomics, for ribosome profil-
ing-assisted experiments a reasonable redundancy can over-
all be presented to the protein inference mechanism without
major influence. As such, the protein inference can be used as
an asset to group redundant identifications in protein groups
at the later stage of MS/MS searching.
For the merge between PROTEOFORMER and UniProt,
most identifications are, at first glance, found in the overlap.
Nevertheless, the MaxQuant protein inference algorithm al-
lows picking up new proteoforms from the combined search
space that could not be explained by searching the UniProt
database alone. As expected from the nature of the algo-
rithms, these newly identified proteoforms were added to the
database by the classic proteoform calling and PRICE meth-
ods and not by SPECtre, because of its dependence on
reference annotation, making it not suited for detecting new
proteoforms. Further, a higher coverage at the ribosome pro-
filing level for Jurkat data compared with HCT116, did result in
more translation product candidates in the total search space,
but it did not remarkably increase the number of MS/MS
identifications (supplemental Table S2). However, the amount
of novel proteoforms did roughly double (supplemental Fig.
S5: panel S5G versus S5D), so it can be generally concluded
that a higher ribosome profiling coverage (and thus a more
comprehensive search space) leads to more novel protein
variants without increasing the amount of canonical protein
identifications. Besides that, more sequencing depth en-
hances the quality and the power of the ribosome profiling
analysis (56).
Next, in Fig. 2D, only 47 proteins out of 4477 (1,05%) are
identified because of UniProt solely (SwissProtTrEMBL).
This raises the point whether reference information is still
useful and could eventually be substituted completely for
custom search spaces in general proteomics experiments. It
is worth discussing but one should bear in mind that it takes
an amount of time to generate these custom databases from
sequencing information, whereas a reference database can
be downloaded directly from its repository. Clearly, this is
study-dependent and here, the combination of both a
ribosome profiling-based search space and a reference is
necessary to separate new proteoforms from known cases.
For samples and species with no or insufficient protein refer-
ence information however, this discussion comes in a totally
different light. In that case, a custom database generated
based on ribosome profiling is of very high value as this
custom database can fulfill the role of the deficient reference.
Further analysis classifies the proteoforms based on the
nature of their variation in a semi-automated fashion. As such,
different categories of proteoforms are validated following
MS/MS. Comparing these classification results between da-
tasets shows that analysis strategies tend to have an influ-
ence on the abundance of specific proteoform categories. It is
thus important to keep in mind the origin and specificities of
all data sources when evaluating the outcome of a proteo-
genomic experiment.
The different new proteoforms can also be manually and
individually checked. At the MS/MS level, examples can be
examined in the MaxQuant interface and on ribosome profil-
ing level, evidence for these same examples can be loaded
into a genome browser of choice using the PROTEOFORMER
BedGraph files. As such, proteoforms can be studied and
viewed in detail at different layers of evidence. Recently, an
even more intuitive way of combining different visual informa-
tion layers has become available by the definition of two
proteogenomic-minded formats: proBAM and proBed (57).
With these formats, results of proteomics analyses can be
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shown on the genomic and transcriptomic level as the pro-
teomic identifications can now be stored in adapted SAM/
BAM or BED files, widely used and able to be visualized by
genome browsers. However, MaxQuant currently outputs a
format which is not convertible to proBAM and proBed yet
(58).
The applied approach, in which a custom search space for
proteomics is obtained from analyzing matching ribosome
profiling with PROTEOFORMER, enables the identification
and validation of new proteoforms. At the same time, this
opens opportunities for genome re-annotation and the results
of this manuscript can be returned to initiatives like Ensembl
(59) and UniProt (30) after manual curation (2). In that way, the
feedback loop will be closed as the initially used reference
information of this study can be complemented and adjusted.
Further, our approach can be extended to data from other
studies. All proteomics data in PRIDE (38) can be rescanned
with a custom search space based on matching ribosome
profiling data. Very recently, the newest update of RPFdb (60)
reported that its database now contains data of 2884 ribo-
some profiling data sets covering 29 species. This allows to
find matching ribosome profiling data for different proteomics
samples in PRIDE. As such, an automated proteogenomics
pipeline of PROTEOFORMER with subsequent MS/MS
searching can even be set up to rescan proteomics data
based on custom ribosome profiling-driven information, ena-
bling a mass scale hunt for new proteoforms and genomic
re-annotation. An example of this semi-automated setup was
run on online RPFdb data of HEK293 cells (SRA project
SRP014629). Analysis of matching N-terminomics MS/MS
data (PRIDE dataset PXD005583) led to the identification of
different classes of proteoforms, but especially uORFs and
N-terminal variations, which is expected given the type of
proteomic data (supplemental Fig. S10). This example dem-
onstrates the usability of the PROTEOFORMER pipeline
and its results for the broader proteomics and genomics
communities.
Proof-of-Concept Proteogenomic Experiment Using
Prosit and Percolator
A first proof of concept based on Prosit (24) for including
MS/MS intensities in the fragmentation spectra identification
process, was issued. MaxQuant uses only the Andromeda
score and a delta score (20) to rate the PSMs. As such, a lot
of information gets overlooked. By using deep learning, Prosit
constructs a collection of additional features for the PSMs
and with Percolator (25, 26) everything is taken together in
one statistical framework. It is shown that these extra features
allow to filter more stringently without lowering the amount of
validated PSMs. On the other hand, different strategies are
applied in both Prosit (24) and Percolator (25, 26) to avoid
overfitting. Further, no additional overfitting is added by com-
bining these two tools as they function as successive steps.
Overall, this first trial case shows that there is a promising
advantage of adding these additional features to the PSM
validation framework and that this can help the proteoform
validation strategy.
The next step for this promising technique is to include the
Prosit features in the protein inference algorithm (26) of Per-
colator to verify whether this results in extra protein identifi-
cations compared to a run with only the MaxQuant scores.
These extra protein identifications can then lead to additional
proteoform validations. Along with Prosit, other tools that
include fragment intensities in their search algorithm like
MS2PIP (61) and Prism (https://github.com/verilylifesciences/
deepmass), can be tested in a proteogenomic context and
eventually added to general proteogenomics workflows (62).
Also, once these next-generation MS/MS search engines are
tested, they can be encapsulated in wrappers, which allow the
total PROTEOFORMER pipeline to be run. For the moment
the pipeline can be run continuous up until the FASTA search
space, but the MaxQuant search engine is still depending on
a GUI. Clearly demonstrated by these first results (Fig. 5), we
believe these MS/MS intensity-based identification strategies,
all based on machine learning, are part of the way forward in
proteogenomics as FDR calculation encounters challenges in
this field because of the extended search space size. Because
of ribosome profiling, this search space size explosion is
somehow tempered compared with a 3- or 6-frame ORF
translation database from RNA-seq (3, 4), but nevertheless,
new approaches to lower the FDR will allow to work more
stringently and validate proteogenomic outcomes with even
more confidence.
CONCLUSION
We report on a complete makeover of the PROTEOFORMER
pipeline, where all newly implemented features of the pipeline
drastically expand its possibilities. The combination of different
proteoform calling methods optimally allows to expand the
search space for MS/MS validation based on ribosome pro-
filing. These efforts show the ability to identify a collection of
MS/MS validated new proteoforms, distributed over differ-
ent possible protein variant types. Moreover, a first step is
taken to include MS/MS intensity-based approaches in a
proteogenomics setup. Together, all these results provide
novel insights for the ribosome profiling-assisted proteog-
enomics research.
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